Mersana Therapeutics Inc banner

Mersana Therapeutics Inc
NASDAQ:MRSN

Watchlist Manager
Mersana Therapeutics Inc Logo
Mersana Therapeutics Inc
NASDAQ:MRSN
Watchlist
Price: 29.08 USD 0.14%
Market Cap: $145.4m

Wall St Price Targets

MRSN Price Targets Summary
Mersana Therapeutics Inc

There are no price targets for MRSN.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Mersana Therapeutics Inc Competitors:
Price Targets
FAST
Fastenal Co
7% Upside
CIGI
Colliers International Group Inc
8% Upside
HCAT
Health Catalyst Inc
-14% Downside
BTBT
Bit Digital Inc
221% Upside
TENB
Tenable Holdings Inc
-26% Downside

Revenue
Forecast

6% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
6% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 4 years is 11%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MRSN's stock price target?
Not Available

MRSN does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Mersana Therapeutics Inc?
Projected CAGR
11%

Over the last 8 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 4 years is 11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett